INTRODUCTION
Heat shock factor 1 (HSF1) is the regulator of heat shock protein (hsp) gene transcription and controls the response to protein stress conserved in eukaryotic cells (1) (2) (3) (4) (5) (6) (7) .
HSF1 senses exposure to stresses such as heat shock at least partially by monitoring the presence of denatured and aggregated proteins in cells (8, 9) . Upon activation, HSF1 trimerizes and binds to the promoters of hsp genes in a hyper-phosphorylated form competent to activate transcription [ (2, 5, (10) (11) (12) (13) (14) .
We have found that, in addition to activating the transcription of hsp genes, HSF1 acts as a repressor of non-heat shock genes (15) (16) (17) (18) (19) (20) (21) . Heat shock inhibits the transcription of many inducible genes involved in macrophage activation and the acute phase response, including interleukin 1 beta (IL-1β), tumor necrosis factor alpha (TNFα), and c-fms through the mediation of HSF1 (15, 17, 18, (20) (21) (22) . In addition, other inducible genes not involved in the specialized function of macrophages, including the immediate early genes c-fos and urokinase plasminogen activator (uPA) are repressed by heat shock and HSF1 (16) . Indeed repression by HSF1 may be a conserved property in eukaryotes as evidenced by the finding that developmental loci in Drosophila, which become repressed during heat shock, are associated with the Drosophila HSF homologue (23) . This capacity for gene repression is specific for HSF1 within the hsf family in mammalian cells and is not a property of HSF2 (16, 20) . We have examined in most detail the mechanism of gene repression by HSF1 in monocytes responding to bacterial endotoxin exposure. We find that the pro-inflammatory IL-1β gene is repressed by HSF1 and that this response is mediated by HSF1 binding to and 
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quenching the activating effect of an essential factor on the IL-1β promoter, nuclear factor of interleukin 6 (NF-IL6/C/EBPβ), which regulates the transcription of many genes in myeloid cells (15, 20, 21, 24) . Our previous studies show that HSF1 binds to NF-IL6 both in vitro and in vivo through the basic zipper (bZIP) region (24) . The bZIP region contains the leucine zipper dimerization domain and DNA binding region common to many bZip family of transcription factors (25) . The bZip region mediates cooperative interactions with a number of other essential transcription factors including, in the case of the IL-1β promoter, Spi1/PU.1 (20, 24, (26) (27) (28) ). HSF1 appears to repress the IL-1β promoter by a mechanism, which involves HSF1 binding to a functional heat shock element (HSE) and interaction with NF-IL6; HSF1 then blocks essential cooperative interactions between NF-IL6 and PU.1 required for IL-1β promoter activation (15, 20) . A similar mechanism appears to be involved in HSF1 repression of the c-fms gene (20) . The HSF1/NF-IL6 interaction may constitute a molecular mechanism involved in the multiple levels of cross talk between the heat shock response and the innate immune/APR response in myeloid cells (20, 29, 30) . Indeed, NF-IL6 activation caused either by overexpression of the protein from transfected expression plasmid or by bacterial endotoxin stimulation of endogenous NF-IL6 leads to the repression of the hsp70b promoter through a mechanism that appears to involve directly HSF1-NF-IL6 binding (21) . It is not known whether other members of the bZIP family including C/EBP, AP-1 binding or ATF / CREB family proteins can interact with HSF1 (31) . Such an interaction could potentially be involved in the repression of genes such as c-fos or TNFα in which NF-IL6 does not play a major role in transcriptional activation.
In the work presented here we have examined the mechanisms of gene repression by HSF1 using mutational analysis to map repression domains. We have found that gene by guest on November 17, 2017 http://www.jbc.org/ Downloaded from 7 281, HSF2 1-222/HSF1 225-529, HSF2 1-222/HSF1 279-529, were constructed by fusing PCR amplified fragments from HSF1 and HSF2 cDNA templates using standard techniques.
The expression plasmid for the full length NF-IL6, pcDNA3.1(-)/NF-IL6, was derived by cloning the entire NF-IL6 cDNA into pcDNA3.1 (-) . A truncated form of NF-IL6, pcDNA3.1(-)/NF-IL6bZIP, was prepared from an internal SplI deletion (amino acid 41 to 205) of the transactivation domain from the full length NF-IL6 cDNA which retained the intact basic zipper (b-ZIP) region (32) . The pcDNA3.1 (+)/HSF-2A, which contains the coding sequence of HSF-2A, was used in in vitro protein interaction assays as control. The expression plasmid for the GST/HSF1 fusion protein contains the full length HSF1 coding sequence inserted in frame downstream of the coding sequence for glutathione-S-transferase in the pGEX vector (Amersham Pharmacia Biotech.). The expression plasmid for the GST-NF-IL6b-ZIP fusion protein contains the truncated NF-IL6 cDNA inserted in pGEX vector and is designated as GST/NF-IL6b-ZIP. The control plasmid, pGEX-2T was used to produce GST control protein.
Transfection methods and assays for luciferase and β-galactosidase
For promoter activity analysis, transient transfection was carried out using the liposomal transfection reagent DOTAP (Boehringer Mannheim). Unless specified in the figure legends, cells were plated in 24-well tissue culture plates at 4 x 10 4 /well and cultured for 18 hr before being transfected with 0.4µg/well of promoter reporter construct. As the control for transfection efficiency, 0.2µg/well of pCMV-βGal expression vector was simultaneously transfected. For co-expression assays, a total 0.4µg/well of expression vector for transcription factors was used. Cells were harvested 18-24 hr after transfection, and the luciferase activity and β-Galactosidase expression levels were assayed according to the 
Western analysis
Nuclear or whole cell extracts were prepared and subjected to SDS-PAGE electrophoresis using standard methodology. Proteins were then transferred electrophoretically onto PVDF (immobilon) membranes (Millipore) as described (33) . The membranes were then blocked by incubation in 1 X phosphate buffered saline (PBS) containing 5% nonfat dried milk and incubated at 4 o C with a specific antibody against the Nterminus of HSF1 (for C-terminal deletion mutants), against the C-terminus of HSF1 (for chimeras and mutants containing complete C-terminus), or against His 6 tag (for mutants with both N-and C-terminal deletions). The membranes were then washed and incubated with a second antibody coupled to horseradish peroxidase (Vector Laboratories). Antigen-antibody complexes were detected by chemiluminescence (ECL, Amersham Pharmacia Biotech).
In vitro transcription and translation of HSF1 and NF-IL6
HSF1 and NF-IL6 were produced in vitro from pcDNA3.1(-) / HSF1, pcDNA3.1 (-) / NF-IL6, and pcDNA3.1(-)/NF-IL6bZIP using a T N T Quick T7 Transcription/Translation kit according to manufacturer's protocol (Promega). HSF1 constructs generated by PCR as described above and cloned into the eukaryotic expression vectors (which contain promoters for in vitro transcription) were used as the templates for in vitro production of truncated proteins for "pulldown" analysis. The in vitro translated proteins were checked for size and integrity by SDS-PAGE analysis and for function by assaying the binding properties to by guest on November 17, 2017 http://www.jbc.org/ Downloaded from 9 oligonucleotides containing specific binding motifs for HSF1 and NF-IL6 using electrophoretic mobility shift assay (EMSA).
EMSA
Nuclear extracts were prepared from cells using NE-PER nuclear and cytoplasmic extraction reagents (Pierce). Briefly, cells were incubated for 10 min on ice in 200 µl CERI solution containing 0.75 mM PMSF, 2.0 µg/ml aprotinin and leupeptin, 20 mM NaF and 2.0 mM Na 3 VO 4 . 11 µl of CERII solution was than added and cytoplasmic extracts were collected by centrifugation at 12,000 g for 5 min. Nuclear pellets were lysed in 100 µl of NER solution containing 2 mM PMSF, 2.0 µg/ml aprotinin and leupeptin. Extracts were then aliquoted and stored at -80 0 C.
The oligonucleotide probes were synthesized and labeled by end filling with 32 P.
Consensus
HSE from human hsp70A gene, 5'-CACCTCGGCTGGAATATTCCCGACCTGGCAGCCGA-3', was used in EMSA.
Each binding mixture (12 µl) for EMSA contained 2.0 µl nuclear extract or 10 µl in vitro translated protein, 2.0 µg bovine serum albumin, 2.0 µg poly dI-dC, 0.5-1.0 ng labeled double stranded oligonucleotide probe, 12 mM HEPES, 12% glycerol, 0.12 mM EDTA, 0.9 mM MgCl 2, 0.6 mM dithiothrietol, 0.6 mM phenylmethylsulfonylfluoride and 2.0 µg/ml aprotinin and leupeptin (pH 7.9). Final concentrations of KCl in the binding mixture were defined for optimal binding of each oligonucleotide. Samples were incubated at room temperature for 15 min, and complexes then analyzed by electrophoresis on 4.5% non-denaturing polyacrylamide gels. The protein-DNA complexes were visualized by autoradiography. 
RESULTS AND DISCUSSION
Functional domains within HSF1 that mediate repression
As our previous studies showed that heat shock represses the transcription of multiple genes, including c-fos, uPA, IL-1β, TNFα and c-fms through a mechanism involving interactions between HSF1 and the target promoters of these genes, we have investigated potential structural domains within HSF1 that mediate repression. We first examined a series of deletion mutants generated from the human hsf1 gene as well as chimeras between hsf1
and the structurally related hsf2 gene. We generated C-terminal truncation mutants by depleting successive 50 codon segments from the 3' terminus of the hsf1 coding region and expressed the fragments in CHO-K1 cells in vivo using a eukaryotic expression vector (Fig.   1A ). After expression in vivo, the mutants were then tested for their ability to repress the activity of co-transfected target promoter-reporter constructs. For this purpose, cells were first transfected with a luciferase reporter construct driven by the human c-fos core promoter and an expression vector for c-fos activator, H-Ras (16). The c-fos core promoter has fairly low basal activity and the activity is induced by exposure of cells to growth factors such as epidermal growth factor (35, 36) . H-ras transfection substitutes for growth factor activation by mimicking the signaling effects of cellular Ras activated by ligand bound growth factor receptors, a system described by us previously (16) . We showed previously that heat shock inhibits serum induced c-fos expression (16) . We have observed that wild type HSF1 is a very effective repressor of the c-fos promoter previously activated either by H-Ras expression or serum stimulation and reduces activity of the reporter luciferase by over 90% (16) (Fig. 1) .
We used the Ras-activated c-fos promoter as a well-defined model system of choice in these studies due to this susceptibility of repression by HSF1. In addition, as c-fos repression by HSF1 does not involve binding to HSE, we were able to concentrate on domains required for functional repression without the complication of taking into account the already characterized DNA binding domain (16) . Our control studies indicated that neither heat shock nor HSF1 overexpression affect Ras synthesis and that the effects of heat and HSF1 are on factors proximal to the c-fos promoter (16) . These effects appear to be downstream of ERK Although the 1-279 fragment efficiently represses the c-fos promoter (Fig. 1B, lane 7) , this mutation has lost all ability to activate the hsp70B promoter as indicated in our control studies ( Fig 1D, compare lanes 2 and 7) , largely due to removal of the C-terminal trans-activation domains (amino acids 379-529). By contrast, overexpression of wild-type HSF1 activates the hsp70B promoter (Fig. 1, D) . Thus, the transcriptional activation domains of HSF1 do not play a major role in trans-repression of target genes. Further deletion from the C-terminus led to the loss of ability to repress the c-fos promoter (Fig. 1B) . Much of the potency of HSF1 to repress c-fos was lost by deletion from codon 279 to 264 and repression was abolished by deletion to codon 205 ( Fig 1B) . We also carried out similar experiments with the c-fms promoter activated by co-transfection with the factor NF-IL6 (Fig. 1C ).
Our previous studies showed that heat shock also blocks the transcription of the endogenous c-fms gene and both heat shock and HSF1 overexpression inhibit the activity of transfected c-fms promoter reporter constructs (20, 21) . We have therefore carried out similar experiments on the c-fms promoter to those on the c-fos promoter described above, using experimental conditions defined in our earlier publication (21) . The results of the deletion experiments were essentially similar, in that HSF1 strongly represses c-fms activity ( 
Role of HSF1 binding to NF-IL6 in gene repression
Our previous studies on repression of the IL-1β and c-fms genes by HSF1 suggest a mechanism of HSF1 repression involving direct binding of HSF1 to the b-Zip region of NF-IL6, indicating a specific molecular target for repression (20, 21) . We have further investigated the potential role of HSF1/NF-IL6 binding in repression (Fig. 4) . We examined the in vitro However, NF-IL6 binding activity was not detected after further deletion to amino acid 179 (Fig. 4 B, lane 18) , even though this polypeptide is synthesized efficiently in vitro and can be expressed stably in cells in vivo (Fig 1E) . This experiment suggests that amino acids between 179 and 205, comprising most of leucine zipper 2 are essential for HSF1 interaction with NF-IL6. HSF1 deletion to amino acid 179 also inhibited the capacity to bind to HSE in the EMSA assay although the protein was still expressed abundantly in cells (Fig. 1E, F) . This region in (Fig. 1) , are not required for NF-IL6 binding (Fig. 4) . The REP domain appears to play a role in gene repression that is independent of NF-IL6 binding. but also increased c-fms activity to 3-fold higher than in cells that had not been exposed to wild-type HSF1 (Fig. 5C ). The mechanism behind this finding is not apparent, although it is possible that endogenous HSF1 may exert a background repressive effect on c-fms that is reversed by the competitive inhibitor HSF1 1-205. This HSF1 truncation mutant, HSF1 1-205 which binds avidly to NF-IL6 (Fig. 4) would be expected to compete for NF-IL6 with HSF1
Development of dominant interfering negative constructs that inhibit repression by
within the cell and this could be at least part of the mechanism for the c-fms superinduction at high levels of co-transfected HSF1 1-205 (Fig 5C) . Similar results were obtained with IL-1β, which is also NF-IL6 dependent (Fig. 5D ). HSF1 1-205 caused an even more pronounced super-induction which may also be due to the reversal of HSF1 repression by endogenous HSF1 (Fig. 5D ). It is notable that this effect was not seen in the c-fos experiments (Fig. 5B) .
Another possibility for some of these effects could be direct binding of HSF1 show that amino acids between 106 and 145 are also essential for repression (Fig. 3) . As our previous experiments have suggested a mechanism for HSF1 repression of IL-1β
involving binding to NF-IL6, we have further pursued this mechanism here (20, 21) . Our current experiments indicate that NF-IL6 binding maps to the N-terminus of HSF1 and that residues in the REP domain are not required (Fig. 4) . Instead, residues in the linker and found. One marked difference between c-fos and c-fms was noted in the study of C-terminal truncations in Fig. 1 B, C. Deletion through the trans-activation domains of HSF1 led to an inhibition of c-fms repression most marked in mutants HSF1 1-429 and 1-379 (Fig. 1C) .
Further truncation to amino acid 279, producing a construct with the "core repression sequence" 1-279, completely restored the repression capacity (Fig. 1C) . These experiments suggest that, in some contexts, sequences in the C-terminus can inhibit gene repression. The exact nature of these interactions is unclear, although one possible mechanism might involve the binding of molecular chaperones to C-terminal sequences in HSF1 that can promote repression. It has been shown previously that hsp70 can bind to sequences in the C-terminus of HSF1, including amino acids 425-439 and block trans-activation of HSP promoters (45).
Our previous studies have shown that hsp70 acts as a transcriptional co-repressor with HSF1
and that intracellular expression of hsp70 antisense oligonucleotides can block gene repression by HSF1, while hsp70 overexpression promotes repression (46) . We suggest that hsp70-containing molecular chaperone complexes that bind to the C-terminus of HSF1 override the C-terminal inhibitory sequences and promote gene repression; hsp70 binding is disrupted by C-terminal truncation (45)and this could account for the inhibition of repression observed in some of the C-terminal deletion mutants. This effect appears to be very pronounced in c-fms while less obvious in c-fos (Figs 1, C, D) . It is not clear whether these differences are due to the design of the model systems used to map repression domains or reflect intrinsic differences between the way HSF1 interacts with c-fos and c-fms.
Our experiments therefore suggest a model in which HSF1 represses inducible genes in part by a mechanism involving the quenching of active transcription factors on target promoters (20) . In an earlier study of IL-1β, we showed that HSF1 binds to NF-IL6 in vivo by guest on November 17, 2017
http://www.jbc.org/ Downloaded from only after NF-IL6 is activated by the proinflammatory lipopolysaccharide and phorbol ester treatment and when HSF1 is activated to a nuclear DNA binding form by heat shock (20) . We suggest a mechanism therefore involving the activation of transcription factors during inflammation or mitogenesis, which migrate to the promoters of genes such as IL-1β, c-fms or c-fos (Fig. 6 ). In the cells that subsequently encounter stresses such as febrile heat, HSF1
is activated to a DNA binding form and migrates to the nucleus as a trimer. (37) . Activated HSF1 is then recruited to the promoters of these induced genes by b-ZIP factors that bind to the NF domain (20) . In support of this, we have found that NF-IL6 binds to HSF1 and competitively inhibits HSF1 binding to heat shock promoters in vitro and represses the activity of heat shock genes in vivo while HSF1 activation leads to inhibition of NF-IL6 dependent genes (20, 21) . HSF1 may thus become tethered to the target promoter through binding to DNA-bound b-ZIP factors and/or by contacting the HSE in genes such as IL-1β and TNFα (15, 18) . HSF1 subsequently represses IL-1β at least partially by quenching essential cooperative interactions between NF-IL6 and Spi.1 (Fig. 6) (20,24) . We have no direct evidence that such mechanism is involved in the repression of the other promoters.
However, the fact that the HSF1 construct 1-205, which contains the NF domain but not the REP domain, acts as a dominant negative inhibitor of repression of IL-1β, c-fms, and c-fos is suggestive of such a general mechanism (Figs. 1 and 5) . However, the molecular mechanisms involved in repression through the REP domain are not clear. The REP domain occupies most of the transcriptional regulatory domain, a region that responds to heat shock and influences the trans-activation domains to induce heat shock promoters (47-49). One possible mechanism for repression by this domain is that the REP domain regulates association of HSF1 with co-repressor molecules (Fig. 6) . Recruitment of co-repressor by guest on November 17, 2017
http://www.jbc.org/ Downloaded from complexes, many of which encode histone deacetylases, has been implicated in the repression of target genes by other factors, most notably the nuclear receptor family (38, 50, 51) . Further experiments will explore this possibility.
In summary, we have found two regions in the HSF1 sequence that are essential in repressing transcription of multiple target genes. These sequences appear to carry out unique functions in gene repression over and above their established roles in HSF1 uncoiling, trimerization, and transcriptional activation in response to stress. were not singlets, we quantitated the most intense band on the autoradiograph. All experiments were performed three times with reproducible results. 
